The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.
We can highlight the next thriving fund investment areas, such as Transportation, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Stemirna Therapeutics, Denovo Biopharma. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Jiuyou Capital, startups are often financed by Zhejiang Xianju Pharmaceutical, ZJU Joint Innovation Investment, Qingyan Lushi Investment. The meaningful sponsors for the fund in investment in the same round are ZJU Joint Innovation Investment, Zheshang Industrial Integration Asset Management, Zhangjiang Torch Venture Capital Co. In the next rounds fund is usually obtained by ZJU Joint Innovation Investment, Innoangel Fund, Eagles Fund.
Related Funds
| Fund Name | Location |
| Acronym Venture Capital | Florida, Palm Beach, United States |
| Bootstrap Advisors | Durham, North Carolina, United States |
| e-LaSer | - |
| HSBC Principal Investments | England, London, United Kingdom |
| Insita Group | - |
| Jiangsu Lianhua Venture Capital | China, Jiangsu, Nantong |
| Klein Venture Partners | California, Cupertino, United States |
| Knickerbocker | - |
| Lionhart Advisors Group | Canada, Ontario, Toronto |
| NextFab | Pennsylvania, Philadelphia, United States |
| Qianhai Haiyun Touzi | China, Guangdong, Shenzhen |
| Quartz | - |
| Radiant Haroti | India, Jaipur, Rajasthan |
| Residual Consulting | - |
| security company | - |
| Shenzhenshi Zhutou Guquan Touzi Jijin Guanli | China, Guangdong, Shenzhen |
| Sparking Capital | Bucharest, Bucuresti, Romania |
| Suzhou Sike Touzi | China, Jiangsu, Suzhou |
| The Blockchainer | China, Shanghai |
| Xinyu Yueyun | China, Jiangxi, Xinyu |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ReLive | $36M | 16 Jan 2023 | - | ||
Maijing Gene | 29 Dec 2022 | Yuexiu District, Guangdong Province, China | |||
Jisi Yingda | 15 Nov 2021 | Shanghai, Shanghai, China | |||
OakMega | 10 May 2021 | New Taipei, Taiwan | |||
Zenshine Pharma | $15M | 01 Dec 2020 | Nanjing, Jiangsu, China | ||
| $154M | 25 Aug 2020 | China, Jiangsu | |||
SmartNuclide | $3M | 23 Apr 2020 | Suzhou, Jiangsu, China | ||
Denovo Biopharma | $46M | 31 Oct 2019 | San Diego, California, United States | ||
| 13 Aug 2019 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ReLive | $36M | 16 Jan 2023 | - | ||
Maijing Gene | 29 Dec 2022 | Yuexiu District, Guangdong Province, China | |||
Jisi Yingda | 15 Nov 2021 | Shanghai, Shanghai, China | |||
OakMega | 10 May 2021 | New Taipei, Taiwan | |||
Zenshine Pharma | $15M | 01 Dec 2020 | Nanjing, Jiangsu, China | ||
| $154M | 25 Aug 2020 | China, Jiangsu | |||
SmartNuclide | $3M | 23 Apr 2020 | Suzhou, Jiangsu, China | ||
Denovo Biopharma | $46M | 31 Oct 2019 | San Diego, California, United States | ||
| 13 Aug 2019 | Beijing |
